GlassScriptPhysician profile
Muhammad Siddiqui
NPI 1841619632
$872.59
in general payments reported to CMS, 2019-2025
15 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.19 · 2023: $318 · 2024: $134 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.05 |
| Education | $112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $160.60 | 2023-2025 | |
| Abbott Laboratories | $136.83 | 2023 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $125.02 | 2022-2025 | |
| Amgen INC. | $93.43 | 2023-2025 | Repatha, Repatha |
| Abiomed | $72.53 | 2022 | |
| Kestra Medical Technology Services, INC. | $54.23 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $45.46 | 2023-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $45.23 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $25.48 | 2024 | Wainua |
| Edwards Lifesciences Corporation | $21.66 | 2025 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $19.67 | 2023 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $19.36 | 2025 | Evkeeza |
| Medicomp INC | $17.96 | 2025 | Telepatch Cardiac Monitor |
| Merck Sharp & Dohme LLC | $17.60 | 2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.53 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.